Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 228 participants.
Also called NCT03354897
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 228 participants
- Registry
-
NCT03354897
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03354897. Allocation not applicable; no masking; primary purpose treatment. Start 2017-04-05 (actual); primary completion 2021-10-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in Hypertension
- Acronym
- UMOD
- Condition
- Cardiovascular Diseases
- Condition
- Hypertension
- Intervention (Drug)
- Torasemide 5Mg Tablet
- Lead sponsor
- NHS Greater Glasgow and Clyde
- Collaborator
- University of Glasgow
- Collaborator
- British Heart Foundation
Record details
- Record id
cardio:ct-nct03354897- Content hash
f42c1cb1fbab4825189394cdf85773d0c872f09cbfc0f3c2999de72f511ca04a